BSG and COVID-19: In our current approach we model SARS-CoV-2 infection in silico with the addition of CD147 gene into KEGG, hereby developing an in silico ‘knock-in’ of the CD147 gene, in order to investigate the role of this extracellular matrix metalloproteinase inducer (EMMPRIN) in COVID-19 (see Supplemental Table S1).